Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Paragon Genomics Launches ParagonDesignertm Online Tool That Makes It Easy To Design Custom CleanPlex® NGS Assays


HAYWARD, Calif., Sept. 20, 2018 /PRNewswire/ -- Paragon Genomics, Inc. today announced the launch of ParagonDesignertm, its web-based tool that enables rapid design of CleanPlex® Custom NGS Panels. The online portal features a streamlined, user-friendly interface that simplifies the assay design process, making it easy for researchers to build customized next-generation sequencing (NGS) assays addressing their specific needs. The custom panels are powered by Paragon Genomics' unique CleanPlex technology, an ultra-high multiplexed PCR-based target enrichment chemistry that makes it possible to include a large number of genomic targets in a single assay.

"ParagonDesigner allows our customers to build CleanPlex Custom NGS assays with just a few clicks of the mouse," said Tao Chen, founder and CEO of Paragon Genomics. "By combining our proprietary target enrichment chemistry and our advanced design algorithm in an assessible online tool, we make it easy for researchers and assay developers to design high quality NGS panels optimized to meet their needs. We provide the best hands-on expert support in the industry to all our customers, and we are proud of our rapid turnaround time?just two to four weeks."

Paragon Genomics design experts are available to provide hands-on personalized support to all ParagonDesigner customers, even for small orders. The company delivers custom NGS panels in 2 to 4 weeks. Other providers typically take six weeks or longer.

With ParagonDesigner, users define the content of their custom NGS assays by submitting their targets online. ParagonDesigner features a database of more than 1,300 pre-designed, clinically-relevant human genes, allowing CleanPlex Custom NGS Panels to be instantly assembled for most applications. The design tool also issues a report on the estimated panel size and design coverage for review prior to submission.

Paragon Genomics' CleanPlex technology is a proprietary, ultra-high multiplexed PCR-based target enrichment technology for NGS featuring an innovative PCR background cleaning chemistry that allows tens of thousands of amplicons to be multiplexed in a single pool of reaction, allowing a large number of targets to be interrogated in a single assay. The CleanPlex technology is combined with Paragon Genomics' advanced panel design algorithm to create optimized custom NGS assays tailored to the user's application and input type, ensuring high sequencing performance and assays that work the first time without further optimization. Users have designed CleanPlex Custom NGS Panels for a wide variety of applications, including tumor profiling, early cancer detection, high-throughput genotyping and gene expression analysis. CleanPlex Custom NGS Panels can be designed for sequencing on either Illumina or Ion Torrent platforms.

For more information about ParagonDesigner and CleanPlex Custom NGS Panels, visit www.paragongenomics.com/custom_panels.

Paragon Genomics' CleanPlex® products are for Research Use Only.

About Paragon Genomics
Paragon Genomics (paragongenomics.com) is a leader in amplicon-based target enrichment and library preparation solutions to accelerate the development of next-generation sequencing (NGS)-based assays for research and clinical testing. The company designs high performance and ultra-multiplexed amplicon NGS panels and develops NGS library preparation chemistries for analyzing difficult, clinically-relevant samples. It strives to make the design of custom NGS assays easily available to a broad range of users, with expert counsel and rapid turnaround. Privately-held Paragon Genomics is located in Hayward, California. 

Contacts:                                

Media:

Paragon Genomics, Inc.     

BLL Partners, LLC

Edward Jan                          

Barbara Lindheim

Head of Product Marketing 

[email protected] 

[email protected]

(917) 355-9234

 

SOURCE Paragon Genomics


These press releases may also interest you

25 avr 2024
The Industrial Technology Research Institute (ITRI) convened the 2024 ITRI Net Zero Day in Taipei, accelerating industry's transition to net-zero emissions. The event highlighted key innovations and successful business cases, focusing on the...

25 avr 2024
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

25 avr 2024
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

25 avr 2024
Bristow Group Inc. , the global leader in innovative and sustainable vertical flight solutions, today announced it will release its first quarter 2024 financial results and selected financial outlook for 2025 and 2026 after market close on Tuesday,...

25 avr 2024
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

25 avr 2024
SUNRATE, an intelligent global payment and treasury management platform has been named one of the Top 100 Cross-Border Payment Companies for 2024 by FXC Intelligence, which recognises and celebrates the most important players in the cross-border...



News published on and distributed by: